APA (7th ed.) Citation

Hohmann, N., Halama, B., Siller, N., Mikus, G., & Haefeli, W. E. (2014). Response to "Can CYP3A activity be evaluated for drug interaction using a nanogram dose of probe drug?": Evaluation of CYP3A activity with microdoses of midazolam. Clinical pharmacology & therapeutics, 95(5), . https://doi.org/10.1038/clpt.2014.28

Chicago Style (17th ed.) Citation

Hohmann, Nicolas, Birte Halama, Nelly Siller, Gerd Mikus, and Walter E. Haefeli. "Response to "Can CYP3A Activity Be Evaluated for Drug Interaction Using a Nanogram Dose of Probe Drug?": Evaluation of CYP3A Activity with Microdoses of Midazolam." Clinical Pharmacology & Therapeutics 95, no. 5 (2014). https://doi.org/10.1038/clpt.2014.28.

MLA (9th ed.) Citation

Hohmann, Nicolas, et al. "Response to "Can CYP3A Activity Be Evaluated for Drug Interaction Using a Nanogram Dose of Probe Drug?": Evaluation of CYP3A Activity with Microdoses of Midazolam." Clinical Pharmacology & Therapeutics, vol. 95, no. 5, 2014, https://doi.org/10.1038/clpt.2014.28.